ABSTRACT
Description: Neumega is a recombinant form of human interleukin 11 (IL-11) that lacks the N-terminal amino acid (proline) and glycocomponent of the natural molecule. The 19-kDa, 177-amino acid polypeptide is produced in Escherichia coli using recombinant DNA technology. Neumega is provided as a lyophilized powder (5 mg/vial) to be resuspended before subcutaneous injection.
